Pacific BioLabs has purchased and validated a QuickPlex SQ 120 MSD instrument and we are now accepting requests for MSD studies. The instrument will be used for immunogenicity testing, biomarker analysis, PK/PD bioanalysis, product development and release assays as well as R&D studies. For a limited time, MSD has offered PBL a discounted rate on specific reagents. Discounts range from 20% to 50% off list prices, please contact PBL for specifics regarding this opportunity.
The MSD platform has many advantages over traditional ELISA methods such as:
- Higher Sensitivity
- Better Dynamic Range
- Less Matrix Affects
- Ability to Multiplex
- Ability to Scale Up
- Less Sample Required
Contact PBL to initiate your MSD project today.